---
title: Prostate cancer detection through unbiased capture of methylated cell-free
  DNA
date: '2024-07-26'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39055933/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240726183330&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Prostate cancer screening using prostate-specific antigen (PSA) has been
  shown to reduce mortality but with substantial overdiagnosis, leading to unnecessary
  biopsies. The identification of a highly specific biomarker using liquid biopsies,
  represents an unmet need in the diagnostic pathway for prostate cancer. In this
  study, we employed a method that enriches for methylated cell-free DNA fragments
  coupled with a machine learning algorithm which enabled the detection of metastatic
  and ...
disable_comments: true
---
Prostate cancer screening using prostate-specific antigen (PSA) has been shown to reduce mortality but with substantial overdiagnosis, leading to unnecessary biopsies. The identification of a highly specific biomarker using liquid biopsies, represents an unmet need in the diagnostic pathway for prostate cancer. In this study, we employed a method that enriches for methylated cell-free DNA fragments coupled with a machine learning algorithm which enabled the detection of metastatic and ...